Data as of Oct 24
| +0.07 / +1.70%|
The 1 analysts offering 12-month price forecasts for Female Health Co have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 7.00. The median estimate represents a +67.46% increase from the last price of 4.18.
The current consensus among 1 polled investment analysts is to Buy stock in Female Health Co. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.